Task: Answer the multiple-choice question.
Query: Which drug exhibits a -9.426% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) CCN(CC)C(=O)CSc1nnc([C@H](CCSC)NC(=O)OC(C)(C)C)o1
b) CN1CCN(C(=O)c2ccc3c(Cl)c4c(nc3c2)CCCC4)CC1
Answer: b. CN1CCN(C(=O)c2ccc3c(Cl)c4c(nc3c2)CCCC4)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1CCN(C(=O)c2ccc3c(Cl)c4c(nc3c2)CCCC4)CC1
CN1CCN(C(=O)c2ccc3c(Cl)c4c(nc3c2)CCCC4)CC1
(9-chloro-5,6,7,8-tetrahydroacridin-3-yl)-(4-methylpiperazin-1-yl)methanone